Drug Discovery Outsourcing Global Market Report 2025

Description

Drug discovery outsourcing involves pharmaceutical companies contracting external organizations to handle various stages of the drug discovery process, such as target identification, lead optimization, and preclinical testing. This practice leverages specialized expertise, reduces costs, and speeds up development timelines.

The main types of drug discovery outsourcing include chemistry services and biological services. Chemistry services encompass specialized chemical expertise, including the synthesis, analysis, and optimization of drug candidates. The workflow typically involves target identification and screening, target validation and functional informatics, lead identification and candidate optimization, and preclinical development. Disease models used in these services include in vitro models, animal models, and cellular models. These services cater to various therapeutic areas, such as cardiovascular, central nervous system (CNS), gastrointestinal, hematology, respiratory, infectious diseases, oncology, immunology, and more. End users include pharmaceutical and biotechnology companies, academic institutions, and other organizations.

The drug discovery outsourcing market research report is one of a series of new reports from The Business Research Company that provides drug discovery outsourcing market statistics, including the drug discovery outsourcing industry's global market size, regional shares, competitors with a drug discovery outsourcing market share, detailed drug discovery outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery outsourcing industry. This drug discovery outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The drug discovery outsourcing market size has grown strongly in recent years. It will grow from $3.92 $ billion in 2024 to $4.24 $ billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to the growing complexity of drug discovery, the need for specialized expertise, stringent regulatory requirements, the globalization of clinical trials, and the rise in demand for orphan drugs and personalized medicine.

The drug discovery outsourcing market size is expected to see strong growth in the next few years. It will grow to $5.72 $ billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing expenses in research and development, patent expirations, the expansion of the biopharmaceutical sector, focus on core competencies, and pressure to reduce time-to-market. Major trends in the forecast period include the adoption of artificial intelligence, technological advancements, big data analytics, specialty drugs, and collaboration and strategic partnerships.

The increasing prevalence of chronic diseases is likely to drive the growth of the drug discovery outsourcing market. Chronic diseases, which are long-term health conditions that can persist for years or a lifetime, are becoming more common due to factors such as an aging population, lifestyle choices, urbanization, and environmental influences. Outsourcing drug discovery helps expedite the development of treatments for chronic diseases by providing access to specialized expertise and advanced technologies, thereby reducing time and costs. For example, in June 2024, the Australian Institute of Health and Welfare reported that 61% of the Australian population, about 15.4 million people, had at least one long-term health condition, which contributed to 90% of deaths in 2022. Conditions like anxiety affected 1.3 million (16%) of individuals aged 0-24 and 1.6 million (22%) of those aged 25-44. Back problems were noted in 1.5 million (23%) of people aged 45-64, and 1.3 million (32%) of individuals aged 65 and older experienced deafness or hearing loss. This rising prevalence of chronic diseases is fueling growth in the drug discovery outsourcing market.

Companies in the drug discovery outsourcing sector are focusing on innovations such as digital health solutions to better serve healthcare professionals, regulators, and patients. Digital health solutions include technologies and services like telemedicine, mobile health apps, and wearable devices that improve healthcare delivery, patient engagement, and health management. For instance, in November 2023, AstraZeneca PLC, a UK-based biopharmaceutical company, introduced Evinova, a health-tech business aimed at advancing life sciences innovation and improving clinical trial delivery. Evinova focuses on global digital products and services that have demonstrated effectiveness in AstraZeneca's clinical trials across more than 40 countries. By enhancing clinical trial design and execution, Evinova aims to streamline new medicine development, reducing both time and costs.

In July 2024, Selvita SA, a Poland-based company specializing in drug discovery, research, and development services, acquired PozLab for an undisclosed sum. This acquisition strengthens Selvita's capabilities in drug development, positioning the company as a comprehensive solution provider in the pharmaceutical industry and expanding its offerings to include small molecule drug manufacturing services for early-stage clinical trials. PozLab is a Poland-based contract development organization that provides end-to-end pharmaceutical development services.

Major companies operating in the drug discovery outsourcing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins SE, Charles River Laboratories, QIAGEN N.V., Curia Global Inc., EVOTEC, Pharmaron Beijing Co. Ltd., Genscript Biotech, WuXi AppTec, Pharmaceutical Product Development, LLC, Syngene International Limited, Jubilant Biosys, Dalton Pharma Services, Oncodesign Services, DiscoverX Corp., Domainex Ltd., Exscientia, TCG Lifesciences Pvt Ltd., GVK Biosciences Private Limited

North America was the largest region in the drug discovery outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug discovery outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug discovery outsourcing market includes revenues earned by entities by providing services such as trial design, site management, patient recruitment, and data collection and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Discovery Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug discovery outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug discovery outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug discovery outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Service Type: Chemistry Services; Biological Services
2) By Workflow: Target Identification And Screening; Target Validation And Functional Informatics; Lead Identification And Candidate Optimization; Preclinical Development; Other Workflows
3) By Disease Model: In Vitro Models; Animal Models; Cellular Models; Other Disease Models
4) By Therapeutic Area: Cardiovascular; Central Nervous System (CNS); Gastrointestinal; Hematology; Respiratory System; Infectious Disease; Oncology; Immunology; Other Therapeutic Areas
5) By End User: Pharmaceutical And Biotechnology Companies; Academic Institutes; Other End Users
Subsegments:
1) By Chemistry Services: Custom Synthesis And Manufacturing; Medicinal Chemistry; Combinatorial Chemistry; Hit Identification And Lead Optimization; Process Chemistry And Scale-Up; Analytical Chemistry Services; Chemical Library Design And Screening; ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Profiling
2) By Biological Services: Cell-Based Assays And Screening; Target Identification And Validation; In Vitro And In Vivo Testing; Biomarker Discovery And Development; Toxicology Studies; Genomics And Proteomics Services; Animal Models For Preclinical Development; Biological Safety And Efficacy Testing; Biopharmaceutical Development And Manufacturing.
Companies Mentioned: Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Eurofins SE; Charles River Laboratories; QIAGEN N.V.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r31797

1. Executive Summary

2. Drug Discovery Outsourcing Market Characteristics

3. Drug Discovery Outsourcing Market Trends And Strategies

4. Drug Discovery Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Drug Discovery Outsourcing Growth Analysis And Strategic Analysis Framework

5.1. Global Drug Discovery Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Drug Discovery Outsourcing Market Growth Rate Analysis
5.4. Global Drug Discovery Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Drug Discovery Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Drug Discovery Outsourcing Total Addressable Market (TAM)

6. Drug Discovery Outsourcing Market Segmentation

6.1. Global Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chemistry Services
Biological Services
6.2. Global Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Target Identification And Screening
Target Validation And Functional Informatics
Lead Identification And Candidate Optimization
Preclinical Development
Other Workflows
6.3. Global Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
In Vitro Models
Animal Models
Cellular Models
Other Disease Models
6.4. Global Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiovascular
Central Nervous System (CNS)
Gastrointestinal
Hematology
Respiratory System
Infectious Disease
Oncology
Immunology
Other Therapeutic Areas
6.5. Global Drug Discovery Outsourcing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Academic Institutes
Other End Users
6.6. Global Drug Discovery Outsourcing Market, Sub-Segmentation Of Chemistry Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Custom Synthesis And Manufacturing
Medicinal Chemistry
Combinatorial Chemistry
Hit Identification And Lead Optimization
Process Chemistry And Scale-Up
Analytical Chemistry Services
Chemical Library Design And Screening
ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Profiling
6.7. Global Drug Discovery Outsourcing Market, Sub-Segmentation Of Biological Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cell-Based Assays And Screening
Target Identification And Validation
In Vitro And In Vivo Testing
Biomarker Discovery And Development
Toxicology Studies
Genomics And Proteomics Services
Animal Models For Preclinical Development
Biological Safety And Efficacy Testing
Biopharmaceutical Development And Manufacturing

7. Drug Discovery Outsourcing Market Regional And Country Analysis

7.1. Global Drug Discovery Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Drug Discovery Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Discovery Outsourcing Market

8.1. Asia-Pacific Drug Discovery Outsourcing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Discovery Outsourcing Market

9.1. China Drug Discovery Outsourcing Market Overview
9.2. China Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Discovery Outsourcing Market

10.1. India Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Discovery Outsourcing Market

11.1. Japan Drug Discovery Outsourcing Market Overview
11.2. Japan Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Discovery Outsourcing Market

12.1. Australia Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Discovery Outsourcing Market

13.1. Indonesia Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Discovery Outsourcing Market

14.1. South Korea Drug Discovery Outsourcing Market Overview
14.2. South Korea Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Discovery Outsourcing Market

15.1. Western Europe Drug Discovery Outsourcing Market Overview
15.2. Western Europe Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Discovery Outsourcing Market

16.1. UK Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Discovery Outsourcing Market

17.1. Germany Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Discovery Outsourcing Market

18.1. France Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Discovery Outsourcing Market

19.1. Italy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Discovery Outsourcing Market

20.1. Spain Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Discovery Outsourcing Market

21.1. Eastern Europe Drug Discovery Outsourcing Market Overview
21.2. Eastern Europe Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Discovery Outsourcing Market

22.1. Russia Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Discovery Outsourcing Market

23.1. North America Drug Discovery Outsourcing Market Overview
23.2. North America Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Discovery Outsourcing Market

24.1. USA Drug Discovery Outsourcing Market Overview
24.2. USA Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Discovery Outsourcing Market

25.1. Canada Drug Discovery Outsourcing Market Overview
25.2. Canada Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Discovery Outsourcing Market

26.1. South America Drug Discovery Outsourcing Market Overview
26.2. South America Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Discovery Outsourcing Market

27.1. Brazil Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Discovery Outsourcing Market

28.1. Middle East Drug Discovery Outsourcing Market Overview
28.2. Middle East Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Discovery Outsourcing Market

29.1. Africa Drug Discovery Outsourcing Market Overview
29.2. Africa Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Drug Discovery Outsourcing Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Drug Discovery Outsourcing Market, Segmentation By Disease Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Discovery Outsourcing Market Competitive Landscape And Company Profiles

30.1. Drug Discovery Outsourcing Market Competitive Landscape
30.2. Drug Discovery Outsourcing Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eurofins SE Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. QIAGEN N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Drug Discovery Outsourcing Market Other Major And Innovative Companies

31.1. Curia Global Inc.
31.2. EVOTEC
31.3. Pharmaron Beijing Co. Ltd.
31.4. Genscript Biotech
31.5. WuXi AppTec
31.6. Pharmaceutical Product Development, LLC
31.7. Syngene International Limited
31.8. Jubilant Biosys
31.9. Dalton Pharma Services
31.10. Oncodesign Services
31.11. DiscoverX Corp.
31.12. Domainex Ltd.
31.13. Exscientia
31.14. TCG Lifesciences Pvt Ltd.
31.15. GVK Biosciences Private Limited

32. Global Drug Discovery Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Discovery Outsourcing Market

34. Recent Developments In The Drug Discovery Outsourcing Market

35. Drug Discovery Outsourcing Market High Potential Countries, Segments and Strategies

35.1 Drug Discovery Outsourcing Market In 2029 - Countries Offering Most New Opportunities
35.2 Drug Discovery Outsourcing Market In 2029 - Segments Offering Most New Opportunities
35.3 Drug Discovery Outsourcing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer